Lowdell Mark William
Insider CIK 1767037 · INMB Chief Scientific Officer, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INMB Inmune Bio, Inc. | X Exercise deriv | 2026-07-02 | 2026-07-07 | 7,211 | $0.13 | $937 | 7,212 | SEC↗ |
| INMB Inmune Bio, Inc. | M Exercise | 2026-07-02 | 2026-07-07 | 7,211 | $1.40 | $10.1K | 1,518,017 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-12-01 | 2025-12-02 | 600,000 | — | $0 | 600,000 | SEC↗ |
| INMB Inmune Bio, Inc. | D To issuer deriv | 2025-11-18 | 2025-11-18 | 180,000 | — | $0 | 0 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-11-18 | 2025-11-18 | 180,000 | — | $0 | 180,000 | SEC↗ |
| INMB Inmune Bio, Inc. | D To issuer deriv | 2025-11-18 | 2025-11-18 | 104,000 | — | $0 | 0 | SEC↗ |
| INMB Inmune Bio, Inc. | D To issuer deriv | 2025-11-18 | 2025-11-18 | 140,000 | — | $0 | 0 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-11-18 | 2025-11-18 | 140,000 | — | $0 | 140,000 | SEC↗ |
| INMB Inmune Bio, Inc. | D To issuer deriv | 2025-11-18 | 2025-11-18 | 100,000 | — | $0 | 0 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-11-18 | 2025-11-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-11-18 | 2025-11-18 | 400,000 | — | $0 | 400,000 | SEC↗ |
| INMB Inmune Bio, Inc. | D To issuer deriv | 2025-11-18 | 2025-11-18 | 400,000 | — | $0 | 0 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-11-18 | 2025-11-18 | 104,000 | — | $0 | 104,000 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2024-12-05 | 2024-12-09 | 140,000 | — | $0 | 140,000 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2024-05-14 | 2024-05-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2024-04-19 | 2024-04-23 | 14,423 | $0.13 | $1.9K | 14,423 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy deriv | 2024-04-19 | 2024-04-24 | 14,423 | $0.13 | $1.9K | 14,423 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award | 2024-04-19 | 2024-04-23 | 14,423 | $8.32 | $120.0K | 1,510,806 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2024-04-19 | 2024-04-24 | 14,423 | $8.32 | $120.0K | 1,510,806 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award | 2022-03-22 | 2022-03-23 | 23,590 | $8.43 | $198.9K | 1,496,383 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2022-03-21 | 2022-03-23 | 104,000 | — | $0 | 104,000 | SEC↗ |
| INMB Inmune Bio, Inc. | S Sale | 2021-11-03 | 2021-11-04 | 701 | $20.00 | $14.0K | 1,472,793 | SEC↗ |
| INMB Inmune Bio, Inc. | S Sale | 2021-10-27 | 2021-10-29 | 2,357 | $20.00 | $47.1K | 1,473,494 | SEC↗ |
| INMB Inmune Bio, Inc. | S Sale | 2021-10-22 | 2021-10-26 | 400 | $20.00 | $8.0K | 1,475,851 | SEC↗ |
| INMB Inmune Bio, Inc. | S Sale | 2021-07-08 | 2021-07-09 | 24,150 | $20.19 | $487.6K | 1,476,251 | SEC↗ |
| INMB Inmune Bio, Inc. | S Sale | 2021-07-07 | 2021-07-09 | 5,850 | $20.02 | $117.1K | 1,500,401 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2019-11-25 | 2019-11-27 | 180,000 | — | $0 | 580,000 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2019-09-11 | 2019-09-12 | 2,918 | $6.23 | $18.2K | 1,506,251 | SEC↗ |